Causes of unexpected death in patients with multiple sclerosis: A forensic study of 50 cases

American Journal of Forensic Medicine and Pathology

Volumn 26, Issue 3, 2005, Pages 244-249

  Riudavets, Miguel Angel ^a,b   Colegial, Carlos ^c   Rubio, Ana ^d   Fowler, David ^d   Pardo, Carlos ^a   Troncoso, Juan C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^d OFFICE OF THE CHIEF MEDICAL EXAMINER   (United States)

Author keywords

Demyelination; Medico legal; Sudden death; White matter

Indexed keywords

ACCIDENTAL DEATH; ADULT; AGED; BRONCHOPNEUMONIA; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CORONER; DEATH; DEMYELINATION; FEMALE; FORENSIC MEDICINE; HOMICIDE; HUMAN; HUMAN TISSUE; INJURY; INTOXICATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MULTIPLE SCLEROSIS; NATURAL DEATH; NEUROLOGICAL COMPLICATION; NEUROPATHOLOGY; REVIEW; SUDDEN DEATH; SUICIDE; THERMAL INJURY; UNITED STATES; WHITE MATTER;

ADULT; AGED; AUTOPSY; CAUSE OF DEATH; FEMALE; FORENSIC MEDICINE; FORENSIC PATHOLOGY; HUMANS; MALE; MARYLAND; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 24644504740     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.paf.0000176277.15834.d3     Document Type: Review

References (28)

1. Prineas J, McDonald W, Franklin R. Demyelinating diseases. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. Oxford University Press. 2002:471-550.
2. Sadovnik AD, Ebers GC, Wilson RW, et al. Life expectancy in patients attending multiple sclerosis clinics. Neurology. 1992;42:991-994.
3. van der Valk P, De Groot CJA. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000;26:2-10.
4. Bo L, Mork S, Kong PA, et al. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J Neuroimmunol. 1994;51:165-146.
5. Trapp BD, Peterson J, Ransoholff RM, et al. Axonal transaction in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278-285.
6. Trapp BD, Bo L, Mork S, et al. Pathogenesis of tissue injury in MS lesions. J Neuroimmnnol 1999;98:49-56.
7. Hafler D. Multiple sclerosis. J Clin Invest. 2004;113:788-794.
8. Lassman H, Raine CS, Antel J, et al. Immunopathology of multiple sclerosis: report on an international meeting held at the Institute of Neurology of the University of Vienna. J Neuroimmunol. 1998;86:213-217.
9. Lucchinetti C, Bruck W, Rodriguez M, et al. Distinct patterns of Multiple Sclerosis pathology indicates heterogeneity in pathogenesis. Brain Pathol. 1996;6:259-274.
10. Phadke JG. Survival pattern and cause of death in patients with MS: results from an epidemiological survey in north-east Scotland. J Neurol Neurosurg Psychiatry. 1987;50:523-531.
11. US Census Bureau, year 2000. Available at: http://www.census.gov/ census2000/states/md.html.
12. Dean G, Elian M. Age at immigration to England of Asian and Caribbean immigrants and the risk of developing multiple sclerosis. J Neurol Neurosurg Psychiatry. 1997;63:565-568.
13. Heinsen H, Lockemann U, Puschel K. Unsuspected (clinically silent) multiple sclerosis: quantitative investigations in one autotopic case. Int J Legal Med. 1995;107:263-266.
14. Phadke JG, Best PV. Atypical and clinically silent multiple sclerosis: a report of 12 cases discovered unexpectedly at necropsy. J Neurol Neurosurg Psychiatry. 1983;46:414-420.
15. Izquierdo G, Hauw GJ, Lyon-Caen O, et al. Value of multiple sclerosis diagnostic criteria: 70 autopsy-confirmed cases. Arch Neurol. 1985;42: 848-850.
16. Poser C, Brinar V. Diagnostic criteria for multiple sclerosis: an historical review. Clin Neurol Neurosurg. 2004;106:147-158.
17. Koch-Henriksen N, Bronnum-Hansen H, Stenager E. Underlying cause of death in Danish patients with multiple sclerosis: results from the Danish multiple sclerosis registry. J Neurol Neurosurg Psychiatry. 1998; 65:56-59.
18. Sadovnik AD, Eisen K. Cause of death in patients attending multiple sclerosis clinics. Neurology. 1992;42:1255.
19. National Vital Statistics Report. 2003;52(3). Available at http://www. cdc.gov/nchs/data/dvs/nvsr52_09p9.pdf.
20. Goldacre MJ. Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979-1998. J Public Health Med. 2003;25:249-253.
21. Knecht J. The multiple sclerosis patient as a driver. Schweiz Med Wachenschr. 1977;107:373-378.
22. Avis SP, Pryse-Phillips W. Sudden death in multiple sclerosis associated with sun exposure: a report of two cases. Can. J Neurol Sci. 1995;22:305.
23. Gleckman AM, Smith T. Sudden unexpected death from primary posterior fossa tumors. Am J Forensic Med Pathol. 1998; 19:303-308.
24. Ortiz-Reyes R, Dragovic L, Eriksson A. Sudden unexpected death resulting from previously nonsymptomatic subependymoma. Am J Forensic Med Pathol. 2002;23:63-67.
25. Jaster JH. Unexpected sudden death after lateral medullary infarction. J Neurol Neurosurg Psychiatry. 2001;70:137.
26. Gleckman AM, Patalas ED, Joseph JT. Sudden unexpected death resulting from hypothalamic sarcoidosis. Am J Forensic Med Pathol. 2002; 23:48-51.
27. Schmidt R. Diseases of CNS myelin. In: Principles and Practice of Neuropathology. 2nd ed. 2003:246-266.
28. Lucchinetti C, Mandler R, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;125:1450-1461.